A history of success
It was in 1990 when Dr. Vicente Carreño, created the Foundation to develop new and effective treatments for liver diseases. His passion for research and professional ambition led him to create a foundation that has given rise to internationally recognized medical breakthroughs.
The idea for the foundation came after visiting the Royal Free Hospital of London (1979-1982), where Doctor Carreño specialized in hepatology.
At this hospital, her tutor, Professor Sheila Sherlock, one of the best doctors specialized in the study of the liver, for which she was nominated six times for the Nobel Prize in Medicine, Dr. Sherlock, president and co-founder of the International Association for the Study of Liver from 1958 to 1962, pushed Dr. Carreño to develop his career in Hepatology.
On his return to Spain, Vicente Carreño completed his doctoral thesis, so that in 1985 he received his doctorate with Cum Laude and Special Prize of the Faculty of Medicine, Autonomous University of Madrid.
He worked as an assistant doctor of the Digestive System Service of the Jiménez Díaz Foundation in Madrid from 1980-1995 and in 1995 he created the Hepatology Service of the Jiménez Díaz Foundation, obtaining the Headquarters of the same and the position of deputy director of research, remaining in that position. Institution until the year 2000. From that date, he moved with all his equipment to the headquarters of the Foundation for the Study of Viral Hepatitis that he had created in 1990. Since then, the FEHV has continued its growth with a specialized Clinic in medical consultations and two laboratories for diagnosis and medical research.
More than 25 years at the forefront of liver diseases
Vicente Carreño start his fellowship at the Royal Free Hospital of Londres, being Sheila Sherlock her tutor.
Vicente Carreño is doctorate with Cum Laude and Special Prize of the Faculty of Medicine, Autonomous University of Madrid.
Creation of the Foundation for the Study of Viral Hepatitis (FEHV) is a non-profit foundation committed to the study of liver diseases.
Discovery of the disease called Mild Idiopathic Ductopenia.
Discovery of a new form of hepatitis, termed “occult infection by the hepatitis C virus”, published in the Journal of Infectious Diseases U.S.A.
Most important achivements
Thanks to these discoveries and to the high analytical technology of our Foundation, we diagnose patients with a liver disease of unknown origin. This allows us to provide with appropriate treatments to patients who previously did not receive any.